Studies conducted in Peru have shown that the Sinopharm vaccine is 94% effective in preventing death in COVID-19 patients, and the population has to understand that this is the principal goal of the vaccination process, affirmed Lely Solari, an infectious disease specialist at the
National Health Institute (INS).
At a press conference, the scientist noted that Peruvians must understand that the population needs to be vaccinated as quick as possible to mitigate the effects of an eventual third wave, and this has to be done with vaccines that are able to prevent death, such as the Sinopharm jab.
"A third wave is very likely to occur (…) the great message is that we need to vaccinate rapidly with the vaccines that we know are effective in preventing death, precisely to prevent high mortality rates in a third wave (…) and
the Sinopharm vaccine is highly effective in preventing it," the infectious disease specialist remarked.
The source she referred to is a survival study of healthcare workers who received the two doses of the Sinopharm shot, which was conducted by the INS, in cooperation with a private university.
This study revealed that the mortality rate declined consistently among the health staff who received the two doses of the vaccine, while the same indicator remained present in the group of professionals who did not receive the antigen injection, which means the Sinopharm vaccine improves the survival of people.
"Its effectiveness against death is 94%. This suggests a fairly high effectiveness, and we are happy to know that it has managed to save many health workers' lives," she said.
The expert also indicated that the Sinopharm vaccine's effectiveness in preventing symptomatic disease is 50.4%.
Solari mentioned that Sinopharm's 78% efficacy in preventing COVID-19 infections at clinical trials has been accredited by the
World Health Organization (WHO), and the studies have been published in the Journal of the American Medical Association, noting that protection against death was not reported because no incident was recorded in such stage.
(END) DOP/RMB
Published: 8/4/2021